Gregory Charles Critchfield

Gregory Charles Critchfield is a notable inventor based in Holladay, UT (US). He has made significant contributions to the field of predictive biomarkers, particularly in relation to pregnancy and preterm birth. With a total of 4 patents, Critchfield's work is at the forefront of medical innovation.

Latest Patents

Critchfield's latest patents include groundbreaking research on biomarker pairs for predicting preterm birth. This patent discloses a pair of isolated biomarkers that exhibit a change in reversal value between pregnant females at risk for preterm birth and term controls. The method involves measuring a reversal value for at least one pair of biomarkers to determine the probability of preterm birth in a pregnant female. Another significant patent focuses on pregnancy clock proteins for predicting due date and time to birth. This innovation offers significantly higher accuracy than current clinical methods and can identify pregnancies that may deliver earlier than the due date derived from Last Menstrual Period (LMP) and obstetric ultrasonography (US) dating.

Career Highlights

Gregory Critchfield is associated with Sera Prognostics, Inc., where he continues to advance research in predictive biomarkers. His work has the potential to transform prenatal care and improve outcomes for mothers and infants alike.

Collaborations

Critchfield collaborates with esteemed colleagues such as John Jay Boniface and Ashoka Dharmapriya Polpitiya. Their combined expertise enhances the innovative research being conducted at Sera Prognostics.

Conclusion

Gregory Charles Critchfield's contributions to the field of predictive biomarkers are invaluable. His innovative patents and ongoing research are paving the way for advancements in prenatal care and improving the health of mothers and their children.

This text is generated by artificial intelligence and may not be accurate.